2022 NHMRC CEO Statement on electronic cigarettes
In 2022 the National Health and Medical Research Council (NHMRC) published an evidence-based Statement on e-cigarettes. This statement includes key messages on health effects, e-cigarette use and uptake, e-cigarette use and tobacco smoking, and advice presented separately for never smokers, former smokers, and current smokers.
To access the interactive online NHMRC resource, containing the 2022 NHMRC CEO Statement on electronic cigarettes and downloadable resources (including evidence reviews, infographics, externally linked resources), please refer to the 2022 National Health and Medical Research Council CEO Statement on electronic cigarettes.
Cancer Australia also supports the Statement from the Chief Medical Officer and State and Territory Chief Health Officers about e-cigarettes and an emerging link between their use and lung disease September 2019 and its recommendations to individuals and health providers regarding e-cigarette use.
The previous Statement on e-cigarettes in Australia published by Cancer Australia in 2018 has been superseded by the two Statements above.
TGA breast implant web statement (2016)
The Therapeutic Goods Administration (TGA) has released a web statement on anaplastic large cell lymphoma (ALCL) in women with breast implants.
Visit www.tga.ov.au for further information.
Position Statement on Breast Density and Screening within the BreastScreen Australia Program (2016)
BreastScreen Australia has announced a position statement on breast density and screening within the BreastScreen Australia program. For further information on breast screening go to BreastScreen Australia.
